ADC Therapeutics (ADCT) Insider Trading & Ownership $3.26 -0.05 (-1.51%) Closing price 09/17/2025 03:59 PM EasternExtended Trading$3.22 -0.04 (-1.23%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADC Therapeutics (NYSE:ADCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.40%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$304KNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$52.48K Get ADCT Insider Trade Alerts Want to know when executives and insiders are buying or selling ADC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ADCT Insider Buying and Selling by Quarter ADC Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/11/2024Redmile Group, LlcMajor ShareholderBuy100,000$3.04$304,000.00 12/4/2024Redmile Group, LlcMajor ShareholderSell25,352$2.07$52,478.64 (Data available from 1/1/2013 forward) ADCT Insider Trading Activity - Frequently Asked Questions Who is on ADC Therapeutics' Insider Roster? The list of insiders at ADC Therapeutics includes Ameet Mallik, Redmile Group, Llc, and Robert Azelby. Learn more on insiders at ADCT. What percentage of ADC Therapeutics stock is owned by insiders? 5.40% of ADC Therapeutics stock is owned by insiders. Learn more on ADCT's insider holdings. Which ADC Therapeutics insiders have been buying company stock? The following insider purchased ADCT shares in the last 24 months: Redmile Group, Llc ($1,428,000.00). How much insider buying is happening at ADC Therapeutics? Insiders have purchased a total of 500,000 ADCT shares in the last 24 months for a total of $1,428,000.00 bought. Which ADC Therapeutics insiders have been selling company stock? The following insiders have sold ADCT shares in the last 24 months: Ameet Mallik ($133,194.88), Redmile Group, Llc ($52,478.64), and Robert Azelby ($20,215.55). How much insider selling is happening at ADC Therapeutics? Insiders have sold a total of 62,078 ADC Therapeutics shares in the last 24 months for a total of $205,889.07 sold. ADC Therapeutics Key ExecutivesDr. Ameet Mallik M.B.A. (Age 51)M.S., CEO & Director Compensation: $1.84MMr. Jose I. Carmona M.B.A. (Age 52)Chief Financial Officer Compensation: $884.86kDr. Mohamed Zaki M.D. (Age 59)Ph.D., Chief Medical Officer Compensation: $2.41MMs. Lisa Michelle KalleboCorporate Controller & Chief Accounting OfficerDr. Michael Mulkerrin Ph.D. (Age 69)Chief Technical Operations Officer Dr. Patrick van Berkel Ph.D. (Age 56)Chief Scientific Officer Amanda HamiltonInvestor Relations OfficerMr. Peter J. Graham Esq. (Age 57)Chief Legal Officer Ms. Eugenia LitzVice President of Investor Relations & Corporate CommunicationsMs. Kimberly Pope (Age 57)Senior VP & Chief People Officer More Insider Trading Tools from MarketBeat Related Companies BHVN Insider Selling HROW Insider Selling JANX Insider Selling COGT Insider Selling SDGR Insider Selling SNDX Insider Selling ABCL Insider Selling AMPH Insider Selling STOK Insider Selling TLRY Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles $100 Million Buyback in Upwork Stock Follows a Strong Quarter Insiders Sell These High-Quality Stocks: Why Investors Shouldn’tCoreWeave and Madrigal's Insider Trades Flash Bullish SignalsPalantir Insider Selling: Risk Signal or Normal Activity?Loop Industries Insiders Buy Stock, Signal Confidence in Outlook This page (NYSE:ADCT) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADC Therapeutics SA Please log in to your account or sign up in order to add this asset to your watchlist. Share ADC Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADCT Stock Alerts